Related Experiment Video
Updated: Jul 2, 2026

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
Published on: May 30, 2017
Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element
Japheth A Opintan1, Mercy J Newman, Owusu Agyemang Nsiah-Poodoh
1Department of Microbiology, University of Ghana Medical School, PO Box 4236, Accra, Ghana.
Objectives:
Vibrio cholerae O1 from a 2006 outbreak in Accra were commonly resistant to multiple antimicrobials and, in particular, to trimethoprim/sulfamethoxazole, drugs commonly used in the treatment of cholera. We sought to determine the genetic basis for trimethoprim/sulfamethoxazole resistance in outbreak isolates.
Methods:
Twenty-seven isolates from the outbreak were screened by PCR and sequencing for class 1 and 2 integrons and for the SXT element.
Results:
Twenty-one of the 27 isolates examined, all from the Accra metropolitan area, carried both SXT, an integrated chromosomal element, and a class 2 integron bearing dfrA1, sat and aadA1 cassettes. All these isolates had identical random amplification of polymorphic DNA profiles and two of them also carried a class 1 integron.
Conclusions:
Most strains characterized carried multiple elements conferring resistance to trimethoprim. This suggests that trimethoprim/sulfamethoxazole should not be used empirically in cholera treatment.
Insights
Vibrio cholerae O1 strains from a 2006 Accra outbreak showed high resistance to trimethoprim/sulfamethoxazole due to multiple genetic elements. This indicates trimethoprim/sulfamethoxazole should not be used empirically for cholera treatment.
Area of Science:
- Microbiology
- Genetics
- Public Health
Background:
- Vibrio cholerae O1 strains from a 2006 outbreak in Accra exhibited widespread antimicrobial resistance.
- Trimethoprim/sulfamethoxazole, a common cholera treatment, was frequently ineffective against these strains.
Purpose of the Study:
- To investigate the genetic mechanisms underlying trimethoprim/sulfamethoxazole resistance in V. cholerae O1 outbreak isolates.
- To identify specific resistance genes and mobile genetic elements contributing to drug resistance.
Main Methods:
- Polymerase chain reaction (PCR) and DNA sequencing were used to screen 27 V. cholerae isolates.
- The study looked for class 1 and 2 integrons and the SXT element.
Main Results:
- Twenty-one of 27 isolates carried the SXT element and a class 2 integron with dfrA1, sat, and aadA1 resistance cassettes.
- All resistant isolates shared identical random amplification of polymorphic DNA profiles, suggesting a common source.
- Two isolates also harbored a class 1 integron.
Conclusions:
- Most V. cholerae O1 strains from the Accra outbreak possessed multiple genetic elements conferring trimethoprim resistance.
- The findings strongly suggest that trimethoprim/sulfamethoxazole should not be used empirically for cholera treatment in this region.
Related Concept Videos
Cholera
Bacterial Gastroenteritis
Stringent Response in E. coli
Reservoir of Infection
Bacterial Translocation and Protein Secretion
Bacterial Toxins

